ANTIBIOTICS MARKET ANALYSIS

Antibiotics Market, By Drug Type (Cephalosporins, Penicillins, Fluroquinilones, Macrolides, Carbapenems, Sulfonamides, Aminoglycosides, and Others), By Spectrum (Broad-Spectrum Antibiotics and Narrow-Spectrum Antibiotics), By Route of Administration (Oral, Intravenous, and Others), By Drug Origin (Natural, Semisynthetic, and Artificial), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Published In : May 2024
Code : CMI5325
Pages :170
Formats :
Excel and PDF
Industry : Pharmaceutical

Market Challenges: Rise in Incidence of Antibiotic Resistance

Rise in incidence of antibiotic resistance is expected to hamper the growth of the global antibiotics market. For instance, antibiotic resistance is a serious public health problem. It occurs when bacteria develop the ability to survive exposure to antibiotics designed to kill them or prevent their growth. Moreover, it results in longer hospital stays, higher medical costs, and increased mortality.

Market Opportunities: Increasing Acquisition by Key Market Players

Increasing acquisition by key market players is expected to offer lucrative growth opportunities over the forecast period. For instance, in September 2021, Lincoln Pharmaceuticals, a pharmaceutical company announced that it had acquired a facility in Gujarat, India to launch Cephalosporin products. It intends to invest USD 3.59 (Rs 30 crores) in the Cephalosporin plant, including capacity expansion and modernization of the facility. The company is planning to manufacture 20 plus Cephalosporin products and is planning to start product registration soon for the domestic and exports markets.